logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Savings for Tazverik

    5 Results

    Eligibility SettingsReset
    0$0
    $0
    $0$10000
    Patient is 18 or older
    Coverage required by the Insurance
    Show funded programs only
    5 Programs Available

    Ipsen Cares Quick Start Program: Tazverik

    Funded
    Commercially Insured
    Medicare / Medicaid
    Underinsured
    Uninsured

    Ipsen Cares Bridge Supply Program: Tazverik

    Funded
    Commercially Insured
    Medicare / Medicaid
    Underinsured
    Uninsured

    PAN: Follicular Lymphoma (Medicare)

    Funded
    Commercially Insured
    Medicare / Medicaid
    Underinsured
    Uninsured
    Max Saving: $2000/year*

    Ipsen Cares Patient Assistance Program: Tazverik

    Funded
    Commercially Insured
    Medicare / Medicaid
    Underinsured
    Uninsured
    Pay as low as
    $0/ fill

    Ipsen Cares Co-Pay Assistance Program: Tazverik

    Funded
    Commercially Insured
    Medicare / Medicaid
    Underinsured
    Uninsured
    Support for Getting Your Patient on Tazverik
    Check medication interactions
    Get patient education materials